Medizinische Beratungsteam im Bereich Onkologie und Hämatologie

Kontakt

We have a dedicated team of over 50 oncology physicians with an average of 23 years of industry and clinical experience, in countries across Europe, North America, Latin America and Asia. Labcorp physicians’ experience extend from translational/early phase development through product launch, late-phase/post marketing studies. 

Unser medizinisches Team wurde sorgfältig ausgewählt, basierend auf klinischen, akademischen und Branchenerfahrungen, die die meisten onkologischen Indikationen einschließlich pädiatrischer Onkologie abdecken.

Within this oncology medical team is a specialized team of oncology medical consultants. Dieses Team bietet Fachwissen im Lebenszyklusmanagement spezifischer Tumorindikationen, einschließlich der Planung und Strategie der klinischen Entwicklung, der Erstellung von Zielproduktprofilen, der Durchführbarkeit des Programms, der Risikobewertung und -ausführung, der Registrierung sowie der medizinischen Überwachung auf Programm- und Studienebene.

Sie werden ihr kollektives Fachwissen während Ihres gesamten klinischen Prozesses mit Ihnen teilen und Sie dabei unterstützen, Onkologiepatienten wichtige Behandlungen sicher und effizient bereitzustellen.


Das Team

Ariel E. Aguiló, MD

Victor Angélico, MD
Senior Medical Director

Victor Angélico, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Paris, France. He provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Angélico performs medical monitoring on assigned projects; reviews protocols, case report forms and other data and materials, and contributes to the scientific leadership of the Oncology area at Labcorp with a special focus in early phase clinical studies and hematological malignancies. Dr. Angélico is board-certified in Internal Medicine and Oncology with 16 years in the clinic and has significant medical and pharmaceutical expertise with 14 years of experience in the pharmaceutical industry. Before his current position, he served as Senior Medical Officer for Chiltern, France and as Medical Director at IQVIA France. Dr. Angelico joined Labcorp in January 2019.

Leerraum

Ariel E. Aguiló, MD

Ariel E. Aguiló, MD
Senior Medical Director

Ariel Aguiló, MD, Senior Medical Director for Labcorp Clinical Development Services in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors. Er bietet Fachkompetenz und Unterstützung bei der Entwicklung und Durchführung von klinischen Studien für die Wirkstoffentwicklungsprojekte von Kunden. Nebenher ist er für das Unternehmen als Fachexperte für dezentrale klinische Studien (DCT – Decentralized Clinical Trials) tätig. Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Labcorp. Er hat 10 Jahre Erfahrung als Arzt, medizinischer Berater und medizinischer Leiter in der Wirkstoffforschung und -entwicklung. Before joining Labcorp, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Labcorp in November 2019

Leerraum

Liliana Baila, MD

Liliana Baila, MD
Senior Medical Director

Liliana Baila, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. Sie fungiert als leitende Projektärztin bei Wirkstoffentwicklungsprojekten von Kunden. Dr. Baila bietet Projektteams medizinische/wissenschaftliche Unterstützung, führt medizinische und Sicherheitsüberwachungen für zugewiesene Projekte durch und entwickelt und überprüft Protokolle, Fallberichtformulare und andere Daten und Materialien. Dr. Baila verfügt über mehr als 25 Jahre Erfahrung als Ärztin, klinische Forscherin und medizinische Leiterin. Before joining Labcorp, she served as Clinical Research Physician for the European Organization for Research and Treatment of Cancer (EORTC) in Brussels. Dr. Baila begann ihre Karriere als Ärztin in Neonatologie und Pädiatrie am Universitätsklinikum in Rumänien. She joined Labcorp in June 2020.

Leerraum

Maria Ignacia Berraondo, MD

Maria Ignacia Berraondo, MD
Senior Medical Director

Maria Ignacia Berraondo, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Berraondo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcrop. Dr. Berraondo hat mehr als 10 Jahre Erfahrung in der Hämatologie und als medizinische Beraterin und Ärztin, wobei sie sechs Jahre in der klinischen Forschung, unter anderem als Direktorin in der klinischen Forschung und Entwicklung, verbrachte. Before joining Labcrop, she served as Medical Director at IQVIA in Buenos Aires. Dr. Berraondo joined Labcrop in July 2020.

Leerraum

Stefanella Bortini, PhD, MD

Stefanella Bortini, PhD, MD
Senior Medical Director

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Milano, Italy. She contributes to the development of Labcorp policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Labcorp. Bevor sie sich dem Unternehmen anschloss, war sie Abteilungsdirektorin für medizinische Angelegenheiten, Onkologie, bei Chiltern International in Mailand. Außerdem hatte sie Positionen bei i3 Research, PRA International, Pharmacia & Upjohn und Eli Lilly inne. Dr. Bortini ist vom italienischen Board of Medical and Surgical Examiners approbiert und verfügt über eine ECFMG-Zertifizierung für die USA. Sie hat einen Abschluss in Medizin von der Universität Florenz in Italien und einen Doktortitel in Biomedizintechnik von der Northwestern University. She joined Labcorp in July 2019.

Leerraum

Stefanella Bortini, PhD, MD

Patricia Brandalise, MD, MsC
Clinical Oncologist

Patrícia Andrade Brandalise, M.D; MsC is a boarded clinical oncologist in Brazil since 2005. Dr. Brandalise earned her M.D. and MsC degrees at Campinas State University (UNICAMP), Brazil, and received her oncology qualifications in the Campinas Institute of Oncology. She is an active member of the Brazilian Society of Oncology. Dr. Brandalise has more than 18 years of experience in clinical oncology with clinical, investigational and administrative responsibilities and 15 years serving in pharmaceutical industry. Previously to joining LabCorp, Patrícia worked for Janssen and Abbvie as Medical Director for Latin America in the Hematology and Oncology Business Unit. She also served as Oncology Medical Leader for Roche Brazil implementing several compassionate use programs in Latin America, preparing, and delivering launches for new molecules/indications. She also has been designing and implementing Phase I-II-III-IV trials in Argentina, Brazil, Colombia, México, Peru, Argentina, Puerto Rico, Korea and Australia, many as lead physician. She joined Labcorp in April 2022.

Leerraum

Stefanella Bortini, PhD, MD

Valery Chatikhine, MD, PhD

Valery is a medical oncologist (MD, PhD), board certified by University of Paris XI and Cancer Research Center of the Russian Academy Medical Science, with more than 10 years medical oncology clinical practice.

He is experienced in oncology drug development Phase 1-3 studies for multiple solid tumors and selected hematologic malignancies with small, large molecules (Immuno-Oncology), ADCs and T cells & NK cells in solid tumors, glioblastoma and lymphoma with FDA and EMA relevant IND/NDAs/BLA submission and approval involvement.

Also, Valery is well published with more than 40 publications in peers review journals (Journal of Clinical Oncology, American Journal of Clinical Oncology, European Journal of Clinical Oncology, Cancer Letters). He is an active member of American Society of Clinical Oncology (ASCO) & Society for Neuro-Oncology (SNO). He joined Labcorp in April 2022.

Leerraum

Stefanella Bortini, PhD, MD

Isagani M. Chico, MD
Vice President and Global Therapeutic Head for Oncology

 

Isagani (Gani) M. Chico, MD, is Vice President and Global Therapeutic Head for Oncology, Labcorp Clinical Development Services, based in Gaithersburg, Maryland. Gani has >30 years of experience in Oncology clinical drug development from small and medium sized biotechnology companies, CROs and the FDA, focused on planning and execution global Oncology clinical development projects from early phase to post approval, leadership of cross-functional strategic teams within medical affairs and clinical development organizations, and management of pharmaceutical, academic and regulatory interactions. Gani earned his medical Degree from the University of the Philippines, completed his Internal Medicine residency at the Cook County Hospital in Chicago, Medical Oncology fellowship training at the National Institutes of Health in Bethesda, MD. He joined in Labcorp in July 2020.

Leerraum

Stefanella Bortini, PhD, MD

Carolina Dutra, MD, MsC
Medical Director

Carolina Dutra, MD, MsC is Medical Director for Labcorp Clinical Development Services, based in Brazil. She is medical oncologist by training and provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Dutra performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcorp. Dr. Mateo has more than 15 years of experience as a physician and principal investigator. She joined Labcorp in May 2021.

Leerraum

Stefanella Bortini, PhD, MD

Jose Espinoza
Senior Medical Director, Therapeutic Area/Oncology

Dr.Espinoza has over 20 years of experience in drug development, which includes enrolling patients into cancer trials, helping design and execute studies, medical monitoring and data analysis of global trials, interfacing with regulatory bodies, and working with biotech and pharmaceutical companies to refine drug development strategies. Worked at PIVOTAL with key opinion leaders to develop new protocols for the treatment of hematological malignancies with CAR T cells . Served as the global medical monitor (USA/EU) in the pivotal Phase 2 study for the accelerated approval of melflufen in relapsed/refractory multiple myeloma by the FDA in February 2021. Dr. Espinoza holds a double specialization: Clinical Oncology (1992-97) and Clinical Hematology & Bone Marrow Transplantation (1997-2001) and has more than 20 years of clinical experience as Consultant Onco-Hematologist at public hospitals in Spain and Ireland. He joined in Labcorp in October 2021.

Leerraum

Jose Daniel Fanjul Fuente, MD

Jose Daniel Fanjul Fuente, MD
Medical Director

Jose Daniel Fanjul Fuente, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. He provides medical and scientific guidance and support to project teams and investigative sites on clients’ drug development projects, and reviews protocols, case report forms, clinical study reports and other data and materials. Dr. Fuente kann mehr als 10 Jahre Erfahrung als Arzt und medizinischer Leiter in der klinischen Forschung und Entwicklung mit Schwerpunkt Onkologie vorweisen. Vor seiner jetzigen Position hielt er Positionen als medizinischer Direktor und Manager in der Onkologie bei IQVIA und Bristol Myers Squibb in Buenos Aires, Argentinien. Bei Bristol Myers Squibb leitete Dr. Fuente wissenschaftliche Aktivitäten, die der Produktlinie des Therapiegebiets Onkologie (Nivolumab und Ipilimumab) Impulse gaben. He joined Labcorp in October 2018.

Leerraum

Begoña de las Heras Garcia, MD

Begoña de las Heras Garcia, MD
Senior Medical Director

Begoña de las Heras Garcia, MD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. She is board certified Medical Oncologist, by La Paz hospital, Madrid, Spain. Begoña joined Labcorp in 2016. Sie fungiert als Projektärztin bei Wirkstoffentwicklungsprojekten von Kunden und liefert medizinisch-wissenschaftliche Expertise für Projektteams/Business Development-Teams. Außerdem führt sie Line-Management-Tätigkeiten einer Gruppe von Ärzten im Studienarm Onkologie aus. She brings more than 20 years of national and international clinical oncology research experience to Labcorp. Vor ihrer derzeitigen Position war sie als Executive Medical Officer, Frühphase, für Chiltern im Vereinigten Königreich tätig. Außerdem hatte sie Positionen in der klinischen Forschung bei Eisai im Vereinigten Königreich und bei verschiedenen Organisationen in Spanien inne, darunter Pivotal CRO, Pharma Mar, AstraZeneca und Bristol-Myers Squibb. She also, was oncologist consult in several hospitals in Spain, General Yagüe Hospital in Burgos, Ntra Sra. Del Prado Hospital in Talavera de la Reina (Toledo) and La Paz Hospital in Madrid.

Leerraum

Begoña de las Heras Garcia, MD

Franklin Gaylis, MD, FACS
Urology Consultant

Franklin Gaylis, MD, FACS, is a Urology Consultant at Labcorp Drug Development. He also serves as Executive Medical Director of Unio Health Partners (UHP), the largest Urology group in California and as a voluntary Professor of Urology at the University of California, San Diego.

Dr. Gaylis is a fellow of the American College of Surgeons, member of the American Urological Association and diplomat of the American Board of Urology. He lectures nationally and internationally on the subject of medical quality and implementation science and is considered a leader in the field. His research has been published in clinical journals such as Urology, Journal of Urology, Urology Practice, American Journal of Medical Quality, and the New England Journal of Medicine. Dr. Gaylis' practice of more than 30 years has been focused on treating early and late stage prostate and bladder cancer including surgical procedures as well as clinical trials, Phase 1-4. He has participated in numerous clinical trials over the past 30 years, serving as PI in many and has 40 publications, 30 of which he is first author. Dr Gaylis has a deep interest in data mining from the EMR and oversees UHP's healthcare informatics program. He has experience with "big data" analytics and is exploring the feasibility for developing synthetic/external controls in Urology at Labcorp. Dr Gaylis provides Urological guidance for therapeutics, diagnostics and biomarker clinical trials and has conducted several advisory boards for sponsors seeking guidance regarding protocols in development. He joined in Labcorp in 2020.

Leerraum

Brian Hamilton, MD, PhD

Brian Hamilton, MD, PhD
Senior Medical Director

Brian Hamilton, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Newton, Massachusetts. He serves as Labcorp Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy. Er ist außerdem als globaler leitender Projektarzt bei Wirkstoffentwicklungsprojekten von Kunden tätig. Dr. Hamilton hat mehr als 35 Jahre Erfahrung in der pädiatrischen Medizin, Immunologie, hämatopoetischen Stammzelltransplantation und klinischen Forschung und Entwicklung. Before joining Labcorp, he served as Executive Medical Monitor for Chiltern International. Er hatte außerdem leitende Positionen als medizinischer Direktor, ärztlicher Direktor für regulatorische Angelegenheiten und klinische Forschung bei Galena Biopharma, AstraZeneca, Onyx Pharmaceuticals, Wyeth Oncology und anderen Pharma- und Biotech-Unternehmen inne. Dr. Hamilton joined Labcorp in August 2018.

Leerraum

Konstantin Haradinov, MD

Konstantin Haradinov, MD
Medical Director

Konstantin Haradinov, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Sofia, Bulgaria. He contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as global lead project physician and provides medical and safety monitoring on assigned projects; reviews medical data and provides clinical and medical expertise to project teams and other Labcorp departments, and performs safety trend analyses. Dr. Haradinov hat mehr als 15 Jahre Erfahrung in der klinischen Forschung als medizinischer Leiter und Arzt/Onkologe. Before joining Labcorp, he served as Medical Officer, Oncology, for Chiltern International in Sofia, Bulgaria. Dr. Haradinov joined Labcorp in April 2019.

Leerraum

He Huang, MD

He Huang, MD
Senior Medical Director

He Huang is Senior Director, Asia Pacific (APAC) for Labcorp Clinical Development Services, based in Shanghai, China. He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Labcorp. Before joining Labcorp, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. Er war außerdem als Leiter für Atemwegserkrankungen bei AstraZeneca und als medizinischer Leiter für gastrointestinale Onkologie bei Roche in Shanghai tätig. Bei AstraZeneca erhielt er den Global Champion and China CEO Award. He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Labcorp in September 2019.

Leerraum

Adrianne Kelly, MD

Adrianne Kelly, MD
Senior Medical Director

Adrianne Kelly, MD, is a Contracted Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey, and Chief Medical Officer of Jude, Peregrine and Kelly Consultants, LLC, in Bethesda, Maryland. Sie fungiert als leitende Projektärztin bei Wirkstoffentwicklungsprojekten von Kunden. Dr. Kelly stellt medizinisch-wissenschaftliches Feedback zu Protokollen und klinischen Entwicklungsplänen bereit, liefert Machbarkeits-Input zu Standorten bezüglich Protokollanforderungen, medizinische Überwachung zugewiesener Projekte und Training für Projektteams. Sie hat mehr als 30 Jahre Erfahrung als Ärztin, klinische Forscherin und Wirkstoffentwicklerin mit Fokus auf Hämatologie/Onkologie. Dr. Kelly erwarb ihren medizinischen Abschluss an der Georgetown University und hat mehr als ein Dutzend Auszeichnungen für Führungsleistungen im Gesundheitswesen und für akademische Leistungen erhalten. Dr. Kelly joined Labcrop in August 2010.

Leerraum

Geoffrey Kannan, PhD, MD

Geoffrey Kannan, PhD, MD
Senior Medical Director

Geoffrey Kannan, PhD, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Labcorp Clinical Development Services, based in Princeton, New Jersey. Dr. Kannan fungiert als globaler leitender Projektarzt für Wirkstoffentwicklungsprojekte von Kunden und bietet medizinisches Fachwissen und Unterstützung bei der Entwicklung und Durchführung klinischer Studien. Dr. Kannan brings more than 10 years of experience as a physician and medical director to Labcorp, specializing in oncology and pediatrics. Before joining Labcorp, he practiced as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist, affiliated with Children's National Medical Center. Davor war er Dozent für Pädiatrie und pädiatrische Neuroonkologe in der Abteilung für pädiatrische Neuroonkologie des Dana-Farber Cancer Institute/Boston Children's Hospital/Harvard Medical School. The author or co-author of many peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Labcorp in November 2018.

Leerraum

Carlo Lanza, MD, PhD

Carlo Lanza, MD, PhD
Executive Medical Officer

Carlo Lanza, MD, PhD, is Executive Medical Officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Labcorp clients. Er leitet frühe Entwicklungsprogramme für die frühe Phase und die Translationsforschung, mit gezielten Therapien, kleinen Molekülen, Biologika und Gentherapie. Dr. Lanza überwacht auch die Ausarbeitung von Entwicklungsstrategien im Spätstadium sowie die Bereitstellung und Genehmigung von Registrierungsprogrammen. Er hat mehr als 20 Jahre Erfahrung in der klinischen Forschung und Entwicklung als Arzt und medizinischer Direktor und ist auf Pädiatrie und Onkologie spezialisiert. Before joining Labcorp, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Dr. Lanza hatte außerdem Führungspositionen bei Novartis Oncology, Pfizer Global R&D und AstraZeneca UK inne. Carlo joined Labcorp in 2012.

Leerraum

Carlo Lanza, MD, PhD

Zarah Dulce Lucas, MD
Senior Medical Director

Zarah Dulce Lucas, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Labcorp Clinical Development Services, based in Princeton, New Jersey. Dr. Lucas serves as global lead project physician on clients' drug development projects, performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcorp. Dr. Lucas brings more than 10 years of experience as a physician, specializing in internal medicine, medical oncology and hematology. Prior to joining Labcorp in 2021, she practiced General Medical Oncology, Benign and Malignant Hematology at Northern Light Eastern Maine Medical Center and also served as principal investigator for several clinical trials, mostly breast cancer studies. She joined Labcorp in January 2022.

Leerraum

Default Profile Picture

Wojciech Massalski, MD
Medical Director

Wojciech Massalski, MD, is Medical Director for Labcorp Clinical Development Services, based in Maidenhead, United Kingdom. Er ist weltweit als leitender Projektarzt bei Kundenprojekten tätig und bietet medizinische Expertise und Unterstützung bei der Entwicklung und Durchführung klinischer Studien. Dies beinhaltet die Überprüfung der Machbarkeit von Wissenschaftsstandorten und die Anwerbung von Studienteilnehmern sowie die Durchführung von Machbarkeits-Risikobeurteilungen und die Datensicherheitsüberwachung bei den zugeordneten Projekten. Dr. Massalski verfügt über mehr als 20 Jahre Erfahrung als Arzt, klinischer Forscher und medizinischer Leiter. Before Labcorp, he was Senior Medical Officer for Chiltern International in the UK. Außerdem bekleidete er Positionen in der klinischen Forschung und medizinischen Überwachung bei Pfizer und Synexus Limited im Vereinigten Königreich. Dr. Massalski joined Labcorp in April 2019.

Leerraum

Valery Novikov, MD, PhD

Maksym Novikov, MD
Senior Medical Director

Maksym Novikov, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Maidenhead, United Kingdom. He serves as global lead project physician on assigned projects, providing medical expertise and support in the development and conduct of clinical trials. This includes reviewing feasibility of investigator sites and recruitment of trial subjects and performing feasibility risk assessment and data safety monitoring, develops and reviews protocols, case report forms and other data and materials on assigned projects. Dr. Novikov has more than 20 years of experience as a physician (surgeon), clinical researcher and medical director. Before Labcorp, he was Senior Medical Officer for Chiltern International in the UK. He also has held clinical research and medical monitoring positions with Novartis, AstraZeneca and other drug development and health care organizations. He joined Labcorp in April 2019.

Leerraum

Valery Novikov, MD, PhD

Valery Novikov, MD, PhD
Senior Medical Director

Valery Novikov, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Paris, France. Sie ist verantwortlich für die medizinische Strategie und die Durchführung klinischer Forschungsprojekte von Kunden. Dr. Novikov prüft Protokolle, Fallberichtformulare, klinische Studienberichte, Anträge für neue Wirkstoffe, Laborwerte, unerwünschte Ereignisse, Datentabellen und andere Daten und Materialien. Außerdem ist sie für die medizinische und sicherheitstechnische Überwachung der ihr zugewiesenen Projekte verantwortlich. She brings more than 20 years of national and international clinical research experience to Labcorp. Before joining Labcorp, Dr. Novikov served as Clinical Study Director for Sanofi in France. Er hatte außerdem Positionen in der klinischen Forschung bei Generium, Helios Clinical Research und PRA International in Moskau, Russland, inne. Dr. Novikov joined Labcorp in August 2019.

Leerraum

Martine Poelman, MD

Maria Parellada, MD
Medical Director

Maria Elvira Parellada, MD, is Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides subject matter expertise in Hematology, supporting development of clinical trials and drug development. Dr. Parellada performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials. Dr. Parellada has 10 years of experience as an hematologist physician; four years in clinical research, as investigator in several clinical trials including acute, chronic myeloproliferative and lymphoproliferative disorders; and currently as medical director in clinical research and development. She is a member of Argentinian Society of Hematology. Before joining Labcorp, she served as MSL Hematology for Janssen Pharmaceutical, at Argentina . She joined Labcorp in August 2021.

Leerraum

Martine Poelman, MD

Martine Poelman, MD
Executive Medical Director

Martine Poelman is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Labcorp clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Labcorp. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Labcorp, providing medical monitoring for more than 200 clinical trials. Before joining Labcorp, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. Vor ihrem Eintritt in die Forschung war sie als Ärztin für Knochenmarktransplantation und Hämatologie/Onkologie in der Abteilung für pädiatrische Onkologie des Wilhelmina Kinderkrankenhauses in den Niederlanden tätig. Martine joined Labcorp in November 1996.

Leerraum

Chia Portera, MD, PhD

Chia Portera, MD, PhD
Senior Medical Director

Chia Portera, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey. Sie evaluiert und etabliert Wirkstoffentwicklungsstrategien für klinische Forschungsprojekte von Kunden und stellt wissenschaftliche/klinische Expertise für Projektteams zur Verfügung. Dr. Portera entwickelt, überprüft und überarbeitet Protokolle, klinische Studienberichte, Anträge für neue Wirkstoffe sowie andere Daten und Dokumente und ist für die medizinische und sicherheitstechnische Überwachung der ihr zugewiesenen Projekte verantwortlich. Sie hat mehr als 10 Jahre Erfahrung als medizinische Onkologin und medizinische Leiterin in der klinischen Forschung und Entwicklung. As a medical director at Genentech before joining Labcorp, Dr. Portera led clinical development strategies of post-market therapies for treatment of HER2+ breast cancer. She joined Labcorp in July 2015.

Leerraum

Kamal Veer Singh Saini, MD

Kamal Veer Singh Saini, MD
Executive Medical Director

Kamal Veer Singh Saini, MD, is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. Er ist ein im Vereinigten Königreich approbierter Facharzt für Onkologie. He contributes to the scientific strategic leadership of the Oncology area at Labcorp, and provides clinical and medical expertise to project teams and other Labcorp departments on clients' drug development projects. Kamal brings more than 15 years of experience in clinical research and development to Labcorp. Zuvor war er als Associate Scientific Director für eine akademische Forschungsorganisation und als medizinischer Berater am Institut Jules Bordet in Brüssel tätig. The author or co-author of several peer-reviewed journal articles, Kamal joined Labcorp in June 2015.

Leerraum

Kamal Veer Singh Saini, MD

Irina Savina, MD, PhD
Medical Director

Irina Savina, MD, PhD, is Medical Director for Labcorp Clinical Development Services in Saint-Petersburg, Russian Federation. She serves as lead project physician on clients' drug development projects, provides medical/scientific expertise to project teams, reviews protocols and medical data, and is responsible for medical and safety monitoring on assigned projects. Dr. Savina has more than 27 years of experience as a physician, research clinician and medical director with therapeutic experience in oncology. Before joining Labcorp, she was Medical Oncologist, Lower Gastrointestinal surgeon, in Saint-Petersburg. She joined Labcorp in February 2010.

Leerraum

Kamal Veer Singh Saini, MD

Maya Ma Seunghyun, MD
Medical Director

Seunghyun Ma, MD, is a Medical Director at Labcorp Clinical Development Services, Seoul, South Korea. She supports clients by serving as a project physician, providing medical expertise & insights, and contributing to the development and implementation of complex clinical trials. Before joining Labcorp, she was the Therapeutic Area Head, Oncology at AbbVie. Previously, she was a clinical research physician at Eli Lilly and Novartis. She had substantial experience as a physician and cancer epidemiologist and in conducting oncology-related cohort studies such as phase 4 clinical trials. She has been an author/co-author of more than two dozen articles in eminent journals. She joined in July 2021

Leerraum

Ivana Teodorovic, MD

Ivana Teodorovic, MD
Senior Medical Director

Ivana Teodorovic, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Labcorp clients. Sie entwickelt, überprüft und überarbeitet Protokolle und koordiniert und führt die medizinische Überwachung und Überprüfung von Patientendaten durch. Dr. Teodorovic kann mehr als 30 Jahre Erfahrung als Ärztin und medizinische Leiterin in der Wirkstoffforschung- und entwicklung vorweisen. Before joining Labcorp, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy. Dr. Teodorovic begann ihre Karriere als zugelassene Pathologin für pathologische Anatomie am Institut für Onkologie und Radiologie in Belgrad, Serbien. She joined Labcorp in May 2005.

Leerraum

Laura Vidal, MD

Laura Vidal, MD
Executive Medical Director

Laura Vidal, MD, is Executive Medical Director for Labcorp Clinical Development Services, based in Madrid, Spain. Dr. Vidal is the Medical Head of the Oncology group in EU. She contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as point of contact for key clients on business oversight; manages relationships with investigators/sites for clinical trials, and mentors clinical research physicians and medical directors across the company. Dr. Vidal hat mehr als 15 Jahre Erfahrung als Ärztin, klinische Onkologin und medizinische Leiterin. Before joining Labcorp, she was Executive Medical Director for Syneos Health in Madrid, and previously served as a physician, medical oncologist, and clinical trials coordinator for a hospital in Barcelona. Dr. Vidal ist Autorin oder Co-Autorin von Dutzenden von Artikeln in Fachzeitschriften und erhielt zahlreiche Gesundheits- und Forschungspreise. She joined Labcorp in December 2020.

Leerraum

Ronald Walls, MD, MBA

Liang Wan, MD, PhD
Medical Director

Liang Wan, MD, PhD, is Medical Director for Labcorp Clinical Development Services in Shanghai, China. He serves as lead project physician on clients' drug development projects, provides medical/scientific expertise to project teams, reviews protocols and medical data, and is responsible for medical and safety monitoring on assigned projects. Dr. Wan verfügt über mehr als 25 Jahre Erfahrung als Arzt, klinischer Forscher und medizinischer Leiter sowie Behandlungserfahrung in den Bereichen Onkologie, Gastroenterologie und Hämatologie. Before joining Labcorp, he was Medical Director for IQVIA in Shanghai, serving as Global or Regional Medical Advisor on assigned projects. Er begann seine Karriere als Chirurg und klinischer Wissenschaftler am Rui Jin Hospital der Shanghai Jiao Tong University. Dr. Wan joined Labcorp in May 2019.

Leerraum

Howard Yeh, MD

Howard Yeh, MD
Senior Medical Director

Howard Yeh, MD, ist Senior Medical Director (Los Angeles, CA) und in Princeton, New Jersey ansässig. Er stellt Kunden medizinische/wissenschaftliche Fähigkeiten vor und nimmt an Diskussionen zur Machbarkeit im Zusammenhang mit Projektvorschlägen teil, baut Kundenbeziehungen und Beziehungen zu Prüfärzten/Standorten für klinische Studien auf und fungiert als leitender Projektarzt bei Wirkstoffentwicklungsprojekten der Kunden. Dr. Yeh verfügt über mehr als 15 Jahre Erfahrung als medizinischer Leiter in der klinischen Forschung und Wirkstoffentwicklung. Before joining Labcorp, he was Medical Director for Johnson and Johnson, Janssen Oncology Clinical Development Services, in Pennsylvania. Zuvor war er als medizinischer Leiter für Amgen Clinical Development Services in Kalifornien tätig. The author or co-author of nearly two dozen peer-reviewed journal articles, Dr. Yeh joined Labcorp in May 2016.

Leerraum

Howard Yeh, MD

Reigetsu Yoshikawa, MD, PhD
Senior Medical Director

Reigetsu Yoshikawa, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services in Osaka, Japan. She contributes to the development of medical strategies and execution of clients' clinical programs and provides medical/scientific expertise to project teams. Dr. Yoshikawa has more than 30 years of experience as a physician, medical director/advisor, and professor of medicine in Japan. Before joining Labcorp, she was Senior Medical Advisor for Eli Lilly and previously served as Senior Medical Lead for Dainippon Sumitomo Pharma in Japan. Dr. Yoshikawa has served on the editorial boards of several peer-reviewed journals and has authored or co-authored dozens of articles, presentations, and abstracts. She joined Labcorp in January 2021.

Unterhalten wir uns

Kontakt